Industry Reports
Sorrento’s TNK Therapeutics Subsidiary to Acquire Virttu Biologics
Sorrento Therapeutics, Inc. Virttu, based in Glasgow, Scotland, is a privately-held biopharmaceutical company focused on the development of oncolytic virus therapy for treatment of cancer. Virttu's lead product candidate Seprehvir® (HSV1716) is a Herpes Simplex Virus...
Industry Reports
CSL Behring Presents Positive Results from CSL112 Phase 2b Trial
CSL Limited -At the American Heart Association (AHA) Scientific Sessions in New Orleans, Louisiana, held on 15 November 2016, CSL Behring announced positive results from AEGIS-I, a Phase 2b safety and proof of mechanism clinical study of CSL112, a...
Industry Reports
Multi Packaging Solutions completes two strategic acquisitions: AJS Labels and i3 Plastic Cards
Multi Packaging Solutions a global leader in value-added print and packaging solutions for the healthcare, branded consumer, and multi-media markets, has completed two strategic acquisitions that complement other operations within MPS and further extend the range of products the...
Industry Reports
Lexicon Pharmaceuticals acquires exclusive rights to development candidate for Neuropathic pain from its alliance with Bristol-Myers Squibb
Lexicon Pharmaceuticals Inc announced that it has obtained exclusive research, development and commercialization rights to LX9211 (BMS-986176), a development candidate for neuropathic pain that was jointly developed by Lexicon and Bristol-Myers Squibb Company as part of their neuroscience drug...
Industry Reports
Medivir strengthens its clinical pipeline by entering into agreement to acquire a portfolio of clinical stage oncology programs
Medivir AB announces that it has entered into an agreement to acquire two clinical stage oncology programs from Tetralogic Pharmaceuticals Corporation , advancing and expanding its clinical pipeline. The acquisition includes remetinostat, a skin-directed HDAC inhibitor,...
Industry Reports
Aralez Completes Acquisition Of Toprol-XL Â And Its Authorized Generic From AstraZeneca
Aralez Pharmaceuticals Inc a global specialty pharmaceutical company announced that its subsidiary, Aralez Pharmaceuticals Trading DAC (Aralez Ireland), has completed its acquisition of the U.S. rights to Toprol-XL® (metoprolol succinate) and its Authorized Generic (AG) from AstraZeneca. ...
Industry Reports
IMS Health and Quintiles Transnational Holdings Merge completed
Quintiles IMS Holdings has successfully completed its merger of equals transaction between IMS Health Holdings and Quintiles Transnational Holdings. The merger of IMS Health, a global information and technology services company, and Quintiles, a provider of...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.
